Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Author: Sagar Pawar
Nitrosamine

ICH M7 for Nitrosamines: Steps for a Lifecycle Management

ICH Guideline M7 provides a solid framework for the management of nitrosamines in medicinal products. By following these guidelines and implementing a comprehensive lifecycle management approach, pharmaceutical companies can effectively minimize the risks associated with nitrosamine impurities. This ensures the safety and effectiveness of medicines, protects public health and ensures compliance with regulations.

Read More »
September 11, 2024
Nitrosamine

Are Nitrosamines Hiding in Your Food? Tips to Avoid Them

Understanding the conditions that lead to nitrosamine formation is crucial for reducing their presence in our food. This article explores the science behind nitrosamine formation in cured meats and offers practical tips for minimizing their levels, ensuring a safer and healthier diet.

Read More »
August 28, 2024
GMP

Top 10 Steps for Qualifying a New GMP Facility

The qualification of a GMP facility is essential to ensure the high standards of pharmaceutical production and to guarantee product quality. In our latest article, you will learn the 10 most important steps for the successful qualification of a new GMP facility to effectively support compliance with regulatory requirements.

Read More »
August 19, 2024
Nitrosamine

NDSRI Regulatory reporting requirements and their timeline

Navigating NDSRI regulatory reporting requirements is crucial for pharmaceutical companies to ensure compliance and patient safety. These regulations mandate timely and accurate reporting of nitrosamine impurities in medicines. Understanding the timeline for these requirements helps streamline processes and avoid costly delays.

Read More »
August 14, 2024
Nitrosamine

6 Steps to reduce nitrosamines impurities in Pharma industry

Implementing effective strategies involves six crucial steps: conducting thorough risk assessments, optimizing manufacturing processes, using high-purity raw materials, performing rigorous analytical testing, adhering to regulatory guidelines, and maintaining continuous monitoring and quality control. These measures collectively minimize nitrosamine risks in pharmaceuticals, ensuring safer medicines for consumers

Read More »
August 5, 2024
Nitrosamine

The Role of Big Data in Nitrosamine Risk Assessment

In the pharmaceutical industry, nitrosamines pose significant health risks due to their carcinogenic potential. This blog explores how big data analytics revolutionizes nitrosamine risk assessment by enabling accurate monitoring and prediction. By leveraging vast datasets and predictive models, companies can manage impurities proactively, ensuring compliance with regulatory standards and enhancing drug safety

Read More »
July 26, 2024
Cleaning Validation

Cleaning Validation: 8 Steps for FDA Compliance Success

Cleaning validation is crucial for FDA compliance in pharmaceutical and food industries, ensuring equipment cleanliness to prevent contamination. It involves meticulous planning, execution, and documentation to verify effectiveness and consistency. Failure to comply can lead to compromised product quality, recalls, and damage to brand reputation.

Read More »
July 17, 2024
Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

Zamann Pharma Support

Consulting Services

Zamed

Pharmatching

Pharmuni

Information

Privacy Policy

Imprint

Need Help?

Request an appointment

info@zamann-pharma.com

Contact us

View Zamann Pharma Support GmbH profile on SAP Business Network Discovery

© 2024 - Zamann Pharma Support